Interview with Elmar Schnee , President of Merck Serono and Member of the…
As a majority family owned group, Merck is also the oldest pharmaceutical company in the world and known throughout…
ProStrakan
Last updated: 13.02.2014
Address: ProStrakan Pharma GmbH
Monschauer Str. 1,
D-40549
Dusseldorf
Germany
Tel: +49 (0) 211/416 119-0
Web: http://www.prostrakan.com/
Company description
ProStrakan is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major markets. With more than 300 people employed by the Company, ProStrakan is headquartered in Scotland with commercial operations throughout the rest of the UK and continental Europe and a US head office. The Company’s Development group is located in Galashiels, Scotland and Bedminster, New Jersey, US.ProStrakan has been listed on the main London Stock Exchange since 2005.
Products and services
Related
Interview with Andreas Fibig, CEO, Bayer Schering Pharma
The 2006 acquisition of Schering by Bayer is a prime example of the way that big pharma is now approaching growth…
Interview with Ralf Göddertz, General Manager of Germany, Austria and…
DAIICHI SANKYO in Germany, Austria and Switzerland DAIICHI SANKYO wants to be a Global Pharma Innovator with…
Interview with Martin Soeters, President, Novo Nordisk Europe
Many companies that are focused in the diabetes segment have recognised the need to strengthen their operations in…
Interview with Arnim Jost, General manager, Cegedim Deutschland GmbH
You joined Cegedim in summer 2006 eleven months before its merger with Dendrite in 2007 that created the world…
Interview with Leonhard Terp, General Manager Specialty Pharma Business Unit,…
The acquisition of Jerini has to be one of the biggest milestones for Shire Deutschland in its recent history. How…
Interview with Harald Stock, CEO, Grünenthal
You arrived at Grünenthal fairly recently, in January of this year. What was it about the company that attracted…
Interview with Hagen Pfundner, CEO, Roche Germany
Roche, once a true pharmaceutical company, is now recognized by its capacity to create a unique business model that…
Interview with Boudewijn Van Bochove , CEO, Biogen Idec Germany
Having experienced many years at big pharmaceutical companies, you recently moved into the booming biotech sector…
Interview with Gernot Köhler, CEO and Owner, Dr. F. Köhler Chemie
Your father was the founder of Dr. Franz Köhler Chemie – that carries his name – and was a very well respected…
Interview with Wolfgang Söhngen, CEO, Paion
Why was the time right in 2000 to start Paion, and how did your background and experiences in the pharma industry,…
Interview with Martin Stapf, Global BU Director Oncology, Hikma Pharma
One of the biggest recent milestones for Hikma’s global operations must have been the acquisition of Ribosepharm…
